Sigma Planning Corp Ampio Pharmaceuticals, Inc. Transaction History

Sigma Planning Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.16 - $0.47 $384 - $1,130	-2,406 Reduced 12.12%	17,442 $3,000
Q1 2022 Apr 20, 2022	BUY	$0.42 - $0.62 $1,555 - $2,295	3,703 Added 22.94%	19,848 $9,000
Q4 2021 Feb 02, 2022	BUY	$0.56 - $1.71 $9,041 - $27,607	16,145 New	16,145 $9,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.